Viking Global Investors
Viking Global Investors is a long/short equity hedge fund. The fund employs a bottom-up fundamental stock-picking strategy for its investments in equities in the U.S. and Europe. It focuses on the financial, telecommunication, media, technology, and consumer sectors. Viking Global Investors is based in New York and was founded in October, 1999 by Andreas Halvorsen, David Ott, and Brian Olson.
Messers. Halvorsen, Ott, and Olson worked together at Tiger Management Corp. All three left Tiger in early 1999.
View Older Stories View More Recent Stories
-
Impossible Foods Releases 2019 Impact Report, Asking, “If Not Us, Then Who?”
-
Synlogic (SYBX) Announces Collaboration with Ginkgo Bioworks to Accelerate Development of Novel Synthetic Biotic Medicines
-
Synlogic and Ginkgo Bioworks Establish Transformational Platform Collaboration for the Accelerated Development of Novel Synthetic Biotic™ Medicines
-
Dan Loeb's Third Point Bets on Humana (HUM) 'Bear Hug' for Centene (CNC) - Sources
-
Form 4 Urovant Sciences Ltd. For: May 21 Filed by: Viking Global Opportunities Illiquid Investments Sub-Master LP
-
Inhibrx Announces $40M Investment from Viking Global Investors
-
Form 4 Urovant Sciences Ltd. For: May 16 Filed by: VIKING GLOBAL INVESTORS LP
-
Form 4 Urovant Sciences Ltd. For: May 16 Filed by: VIKING GLOBAL PERFORMANCE LLC
-
Viking Global's 13F Shows New Stakes in Activision Blizzard (ATVI), Allstate (ALL), JD.com (JD), Micron (MU) (More...)
-
Form 13F-HR VIKING GLOBAL INVESTORS For: Mar 31
-
BURGER KING® Restaurants Introduces the Plant-Based Impossible™ WHOPPER® in Three New Markets
-
Exclusive: Impossible Foods raises $300 million with investors eager for bite of meatless burgers
-
Astarte Medical Secures $5 Million in Series A Financing to Advance its Technology for Improving Preterm Infant Outcomes
-
QDOBA Mexican Eats® Adding Impossible™ to Restaurants Nationwide by May 28
-
White Castle® Celebrates First Anniversary Of Impossible Slider, Slides New Impossible™ Foods Recipe Into Restaurants Across The U.S.
-
BURGER KING® Restaurants Test the Impossible™ WHOPPER®
-
Form 4 Axovant Sciences Ltd. For: Mar 18 Filed by: Viking Global Equities LP
-
Form SC 13D/A Axovant Sciences Ltd. Filed by: VIKING GLOBAL INVESTORS LP
-
Form D/A Viking Global Equities
-
Form D/A Viking Global Equities
-
Form D/A Viking Global Equities
-
Ginkgo Bioworks Launches Motif Ingredients with $90 Million Series A Financing
-
Form SC 13G/A BERRY GLOBAL GROUP INC Filed by: VIKING GLOBAL INVESTORS LP
-
Viking Global's 13F Shows New Stakes in Adobe (ADBE), American Airlines (AAL), Boeing (BA), Zillow (ZG), Increase in Alibaba (BABA) (More...)
-
Form 13F-HR VIKING GLOBAL INVESTORS For: Dec 31
-
QDOBA Mexican Eats® Tests Impossible™ in Select Michigan Locations
-
Hercules Capital Announces Multiple Outstanding Achievements by Numerous Investment Portfolio Companies
-
Apeel and Nature's Pride Team Up to Take the Food Waste Fight to Europe
-
Umami Burger Launches Impossible Foods New Recipe Of The Impossible Burger
-
Form SC 13G/A Parsley Energy, Inc. Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G/A UNITED STATES STEEL CORP Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G/A Deciphera Pharmaceutical Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G/A Jianpu Technology Inc. Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G/A BERRY GLOBAL GROUP INC Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G/A aTYR PHARMA INC Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G/A Myovant Sciences Ltd. Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G/A Moderna, Inc. Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G/A Eidos Therapeutics, Inc. Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G/A MIDDLEBY CORP Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G/A ENCANA CORP Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G/A ABEONA THERAPEUTICS INC. Filed by: VIKING GLOBAL INVESTORS LP
-
Form 3 Urovant Sciences Ltd. For: Jan 01 Filed by: Viking Global Equities Master Ltd.
-
Form 3 Axovant Sciences Ltd. For: Jan 01 Filed by: Viking Global Equities Master Ltd.
-
Form 3 Myovant Sciences Ltd. For: Jan 01 Filed by: Viking Global Equities Master Ltd.
-
Form 3 Arbutus Biopharma Corp For: Jan 01 Filed by: Viking Global Equities Master Ltd.
-
Form D/A Viking Global Opportunit
-
Form D/A Viking Global Opportunit
-
Form SC 13D/A Urovant Sciences Ltd. Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13D/A Arbutus Biopharma Corp Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13D/A Axovant Sciences Ltd. Filed by: VIKING GLOBAL INVESTORS LP

